Full Press Release Details
IGAMBIT Announces Sale of Gotham
Press Release: iGambit Inc. - Tuesday November 11, 2015 2 PM EST
SMITHTOWN, NY., November 11, 2015 Marketwire/ -- iGambit Inc. (OTCQB: IGMB), a
diversified holding company, announced that on November 5, 2015, through its wholly owned
subsidiary Gotham Innovation Lab, Inc. ("Gotham") it sold certain assets of the Gotham business
to VHT, Inc ("VHT").
A copy of the Form 8-K report may be accessed at www.sec.gov.
John Salerno, Chairman and CEO of iGambit, said, "Gotham has been a useful and rewarding
subsidiary and we wish VHT much success with this new acquisition. We will use the proceeds
of the sale to further our business efforts with our recently acquired email archiving management
solutions business, ArcMail."
About iGambit Inc: iGambit (OTCBB: IGMB) is a fully reporting publicly-held company. We
are a diversified holding company pursuing and evaluating a number of strategic objectives. These
objectives include, among others, the potential acquisition of small to medium size businesses. We
believe that the background of our management and of our Board of Directors in the technology
markets is a valuable resource that makes us a desirable business partner to the companies that we
are seeking to acquire. When we acquire a company, we work to assume an active role in the
development and growth of the company, providing both strategic guidance and operational
support. Once a company joins our partner company network, our collective expertise is leveraged
to help position that company to produce high-margin, recurring and predictable earnings and
generate long-term value for our stockholders. For more information, please visit
www.igambit.com. Information on our website does not comprise a part of this press release.
Cautionary Note Regarding Forward-Looking Statements
Certain statements in this document and elsewhere by iGambit are "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act of 1995. Such information
includes, without limitation, the business outlook, assessment of market conditions, anticipated
financial and operating results, strategies, future plans, contingencies and contemplated
transactions of the company. Such forward-looking statements are not guarantees of future
performance and are subject to known and unknown risks, uncertainties and other factors which
may cause or contribute to actual results of company operations, or the performance or
achievements of the company or industry results, to differ materially from those expressed, or
implied by the forward-looking statements. In addition to any such risks, uncertainties and other
factors discussed elsewhere herein, risks, uncertainties and other factors that could cause or
contribute to actual results differing materially from those expressed or implied for the forward-
looking statements include, but are not limited to fluctuations in demand; changes to economic
growth in the U.S. and U.S. government policies and regulations, including, but not limited to
those affecting the medical fertility clinic industry. iGambit undertakes no obligation to publicly
update any forward-looking statements, whether as a result of new information, future events or
otherwise. Actual results, performance or achievements could differ materially from those
anticipated in such forward-looking statements as a result of certain factors, including those set
forth in iGambit Inc.'s filings with the Securities and Exchange Commission.
Investor Relations Contacts:
American Capital Ventures